People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Venn Biosciences Corp | — | Biotechnology | Series D+ | $214.6M | $5.0B | 2018 |
Klaus Lindpaintner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Klaus Lindpaintner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adam D'Augelli | 1 | 13 |
| David Michael | 1 | 6 |
| Jenny Rooke | 1 | 5 |
| Aldo Carrascoso | 1 | 2 |
| Lieza Danan-Leon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.